XML 12 R39.htm IDEA: XBRL DOCUMENT

JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended		101 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012
Cash paid at formation	$ 0	$ 0	$ 4,058
Lipimetix [Member]
Patent license rights	(1,045)		(3,187)
Noncontrolling interests	(667)
Cash paid at formation	$ 378		$ 4,436

The amount of intangibles that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.

+ References+ Details